AzTrials
AzTrials

Critical IllnessNCT05094388

Validation of Prediction Model of Vitamin D Deficiency

An observational study of Critical Illness, run by National Taiwan University Hospital at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Many studies have pointed out that patients with vitamin D deficiency have a longer stay in the intensive care unit and a poor prognosis. The investigators' previous multi-center prospective observational study in Taiwan reveals that the prevalence of vitamin D deficiency in critically ill patients in northern Taiwan… Read more about this study

Who is it for?
Ages 20 years and older
Conditions the study is for
Critical Illness
What is being tested?
Admitted to intensive care units
How many people
400 participants
Where
1 siteTaiwan
Study dates
10 Nov 2021to Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Critically ill patients admitted to intensive care units

Who may be able to join

  • Patients admitted to intensive care units

Who cannot join

  • aged < 20 years
  • admitted to intensive care unit longer than 28 days
  • body max index < 18 kg/m2
  • receive vitamin D supplement > 3000 IU/day
  • previously admitted to intensive care unit within 3 months
  • have parathyroid disease, rickets, or severe liver cirrhosis [Child C]

Trial locations and contacts

1 site in 1 country.

Yu-Chang Yeh, MD, PhD contact

+886-9-68661829

tonyyeh@ntuh.gov.tw

Taiwan1 site, 1 recruiting
  • National Taiwan University Hospital

    Taipei, 10002

    Yu-Chang Yeh, MD, PhD, +886-968661829, tonyyeh@ntuh.gov.tw

    Recruiting

Other trials in Taiwan

About this study

Official title: Validation of Prediction Model of Vitamin D Deficiency in Critically Ill Patients

Many studies have pointed out that patients with vitamin D deficiency have a longer stay in the intensive care unit and a poor prognosis. The investigators' previous multi-center prospective observational study in Taiwan reveals that the prevalence of vitamin D deficiency in critically ill patients in northern Taiwan is 59%, and the prevalence of severe vitamin D deficiency is 18%. The investigators used the data of that observational study to train a predictive model for predicting vitamin D deficiency. In addition, the association between vitamin D and the immune regulation of critically ill patients in Taiwan has not been investigated. This study aims primarily to validate the performance of the prediction model of vitamin D deficiency. Moreover, this study will investigate the association between vitamin D level and inflammatory cytokine levels.

This multi-center prospective observational study will enroll critically ill patients admitted to intensive care units (ICUs) less than 28 days. After inform consent, blood will be drawn for examination of vitamin D, interleukin 6, and interleukin 10 levels. The main diagnosis of ICU admission, past medical history, vital signs within 24 hours of admission, disease severity, and laboratory data will be recorded. The predictive model will use the required parameters to predict the patient's risk of vitamin D deficiency and vitamin D severe deficiency.

Being tested
Admitted to intensive care units
Keywords
critical care, vitamin D
Medical subject headings
Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Admitted to intensive care unitsOther

    Admitted to intensive care units

Study groups in NCT05094388
Study groupRoleWhat they receive
Critically ill patientsPatients admitted to intensive care units
Receives: Other: Admitted to intensive care units

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Area under the receiver operating characteristic

    Area under the receiver operating characteristic of the prediction model of vitamin D deficiency

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2021
  2. Study start10 Nov 2021
  3. Primary completionAug 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05094388
Sponsor's protocol ID
202106128RIND
Status last verified
Feb 2024
First submitted
14 Oct 2021
Last updated
20 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Critical Illness, run by National Taiwan University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yu-Chang Yeh, MD, PhD (+886-9-68661829, tonyyeh@ntuh.gov.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Area under the receiver operating characteristic (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in